Assessing similarity is highly important for bioinformatics algorithms to determine correlations between biological information. A common problem is that similarity can appear by chance, particularly for low expressed entities. This is especially relevant in single cell RNA-seq (scRNAseq) data because read counts are much lower compared to bulk RNA-seq.
Introduction
Single cell RNA-seq (scRNA-seq) is one of the most recent advances in single cell technologies and it has been widely used to study multiple biological processes [64, 7, 21, 20, 12, 55, 23, 73, 51] . Standard bulk RNA-sequencing retrieves the average of RNA expression from all cells in a specific sample, thus providing an overall picture of the transcriptional activity at a given time point from a mixed population of cells. However, within the study of heterogeneous populations it is not possible to understand the contribution of individual cell types which is needed to dissect precise mechanisms. Single-cell RNA-seq (scRNA-seq) overcomes the limitations of bulk RNA-seq by sequencing mRNA in each cell individually, making it possible to study cells at a genome wide transcriptional level within heterogeneous samples.
However, due to the small amount of mRNA sequenced within a cell, typically 80-85% of all genes remain undetected, a phenomenon known as dropout. This results in an incomplete picture of the mRNA expression pattern within a cell.
ScRNA-seq observations are biased because false zero counts occur in most genes because of the low amount of mRNA sequenced in each cell. There are several methods to correct for the dropout by imputing gene expression based on the gene expression of other cells. For example, MAGIC corrects gene expression with the gene expression of other cells modelled as a diffusion map [71] . scImpute corrects the dropout using similar cells and genes not affected by dropout [34] . SAVER uses a negative binomial to model gene expression in each cell and corrects dropout using the expression of other genes as predictors in a LASSO regression [24, 69] . All these methods follow the same principle by sacrificing part of the single cell structure of the data in order to obtain a better resolution of the different populations.
A similarity measure in mathematics is a function (with real values) that quantifies how similar two objects are. In the context of this project, we aim to determine similarity of genes in two distinct conditions. Several techniques use different notions of similarity to visualize data such as PCA or t-SNE. Several techniques exist to cluster data in scRNA-seq, such as Seurat [10] , SCENIC [3] or Cell Ranger [78] . There are methods that use the notion of similarity to infer the gene regulatory dynamics. Some examples are SCENIC [3] or NetworkInference [13] . These techniques rely on data transformations and corrections of the dropout, but do not incorporate a notion of uncertainties in the measurements.
Assessing similarity between genes have previously been used in biology for biomarker discovery in cancer [39, 14] , find patterns in gene expression [29] or to build gene expression networks [11, 68] .
However, assessing similarity can be challenging since measurements of small populations with large uncertainties may lead to false correlations. If a gene's expression is so low that it only registers zero or a few reads per cell, then its expression pattern across cells cannot be meaningfully related to that of other genes, there is simply too much uncertainty about the real expression levels of that gene. In a typical scRNA-seq dataset, the majority of genes may be in this situation, so that gene-gene correlation analysis is swamped with meaningless or spurious correlations.
Noise in gene expression measurements has been modeled and studied to identify differentially expressed genes [36, 31, 70] . Recently, uncertainties have been incorporated in methods to study differential expression in RNA-seq experiments [52] and a Bayesian scheme has been proposed to identify differentially expressed genes in scRNA-seq [63] . Noise is especially important in scRNA-seq because the low number of read counts. Therefore, methods to assess similarity in bulk RNA-seq may not be appropriate for scRNA-seq. Thus, methods need to be modified properly in order to maintain reproducibility. A simple solution is the removal of cells with a low number of read counts and low expressed genes, which is the currently used method of single-cell analysis [37] . However, there is not a systematic method to select a threshold and it highly depends on the population being studied.
In order to address limitations dependent on the noise, Bayesian statistics have been used to study biological processes [75, 74] . Recently, we have proposed a Bayesian correlation scheme to asses similarity between two entities in high-throughput sequencing (HTS) experiments [60, 56] . Such Bayesian correlation consider uncertainties in the measurements. And therefore, assign low values to correlations coming from low expressed genes using a prior belief and compute posterior belief based on data observation. Using this method, we have identified that a correct choice in the prior is crucial.
Thus, we set out to develop new Bayesian methods to create better clustering algorithms than the ones currently available.
An additional consideration that needs to be addressed in scRNA-seq experiments is the number of sequenced cells. Simulation methods for scRNA-seq data is not a mature field and could not reproduce all the biological mechanisms present in an experiment. To study the effect of the number of cells on the reproducibility of the results, we sequenced parenchymal and non-parenchymal cells from a mouse liver. To test the sensitivity of the methods, 4 samples with an increasing number of input cells were explored (1000, 2000, 5000 and 10000 cells). To avoid biological noise, samples sequenced were from the same animal.
In this manuscript we show that Bayesian correlation is a robust similarity measure for pairs genes in single cell RNA-seq. We show that the reproducibility of Bayesian correlation is higher than the reproducibility of Pearson correlation. We show that the results obtained with Bayesian correlation have a small dependence to the number of cells, making the method suitable to study rare populations.
Finally, we show that biologically relevant genes tend to appear more often in the top correlated pairs using Bayesian correlations.
MATERIALS AND METHODS

Mathematical Formulation of the Bayesian Correlation Method
After counting the aligned reads to exons and debarcoding the reads from cells, the output of a scRNAseq experiment is the n × m unique molecular identifiers (UMI) matrix, R, where n is the number of genes and m the number of cells. Ideally we would correlate the true fraction of UMIs, p ie , of gene i in cell e. A trivial approximation is to normalize the data dividing every UMI by the total number of UMIs in that cell, that is p ie ≈ R ie R e . Bayesian schemes try to approximate p ie using a prior belief and compute posterior belief based on data observation.
Assume we have R ie UMIs of gene i in cell e and the total UMIs in that cell is R e . The empirical estimate is p ie = R ie Re . Then, Pearson correlation can be computed as
where (α 0 ie , β 0 ie ) is the prior. In that scenario the covariance and variance are computed as
and V ar(p ie ) = E(V ar(p ie |e)) + V ar(E(p ie |e)),
with
Then, the Bayesian Correlation is defined as
Cell isolation
Hepatocytes were isolated by a two-step collagenase perfusion. Animals were anesthetized (fentanyl 50ug/kg, midazolam 5mg/kg, medetomidine 500ug/kg, i.p.), immobilized in a supine position and the liver and portal vein exposed. The portal vein was cannulated with a 22G catheter and perfusion at 4ml/min with the buffers allowed to run to waste through an incision in the inferior vena cava. The liver was perfused with 10 ml of HBSS (Mg2+, Ca2+ free,10mM HEPES, pH7 ) followed by 25ml of HBSS containing EDTA ( 10mM HEPES pH7, 5mM EDTA). The EDTA was removed from the liver by perfusion with 10 ml of HBSS followed by digestion with 25 ml of HBSS containing collagenase ( 10mM HEPES, 1mM CaCl2, 0.5mg/ml collagenase IV, 0.01mg/ml collagenase 1A (Sigma)). The liver was then removed and the cells released by cutting the capsule and gentle agitation of the digested liver in stop buffer (HBSS, 10mM HEPES pH7, 5mM EDTA, 10mM citrate, 1% FBS) and passed through a 70µm filter. The cell suspension was spun at 30G min to pellet most of the hepatocyte fraction, the supernatant collected and remnant cells pelleted at 250xG. This cell pellet was washed once in stop buffer then re-suspended in 20% isotonic Percoll and overlaid on a layer of 80% isotonic Percoll and spun at 500G for 10 minutes. The cells at the interface of the two Percoll layers were collected and washed in PBS, re-suspended in PBS and counted using a cell counter (BioRad TC 20).
Library preparation
scRNA-seq libraries were prepared from 1000, 2000, 5000 and 10000 cells using the Chromium Single 
Sequencing
Sequencing was performed on a NovaSeq 6000 S2 flow cell. Read 1 consisted of 26 cycles (10XGenomics barcode plus UMI) followed by a single illumina i7 index read of 8 cycles and read 2 of 91 cycles to determine transcript-specific sequence information.
Read alignment
The function cellranger count from Cell Ranger was used to transform the fastq files with the parameter expect-cells set to 1000, 2000, 5000 or 10000. The reference genome was the mm10 available at Illumina Cell Ranger webpage. Next, we used cellranger mat2csv to generate the UMI matrix.
Data pre-processing
First, we created an SCE object with the function SingleCellExperiment from the R-package Single-CellExperiment.
The UMI matrix was filtered as follows: first, genes with 0 reads where excluded; second, cells with more than 15% of UMIs in mitochondrial genes were removed (mitochondrial gene list is included in suplementary materials). Cells with more than 25% UMIs in globin genes were removed. Finally, genes expressed in less than 2 cells were removed. Additionally, for the 5000-sample, a cell containing 110270 UMIs was considered an outlier and it was removed because the second cell with most UMIs had 26038 UMIs.
Dimensionality reduction and clustering
In order to cluster the data and find the different cell populations and their markers, we followed the procedure of Seurat [10] . The filtered UMI matrix was transformed into a Seurat Object with
CreateSeuratObject with parameters min.cells = 1 and min.genes = 2. We normalised the data with the R-function NormalizeData from Seurat with parameters: normalization.method = "LogNormalize"
and scale.factor = 10000. Then, the data was scaled with the Seurat function ScaleData with parameter vars.to.regress = c("nUMI") The different clusters were identified using the Seurat function 
Drop-out correction
We corrected the dropout from the UMI matrix with the magic function form the R-package Rmagic with the parameters genes set equal to "all_genes" and default parameters. Any resulting negative expression was replaced with 0.
Notions of similarity
In this manuscript, we consider 3 notions of similarity between genes: 1-All cells correlation: The correlation of gene i and gene j is the correlation coefficient using all cells. 2-Cluster correlation:
The correlation of gene i and gene j is the correlation coefficient using each cluster as condition, where the gene expression is the sum of the gene expression in all cells. That is, let K be the number of clusters, let (RC j in ) be the UMIs of gene i of cell n in cluster j. We transformed our K matrices in the reduced n × k dimensional matrix (B ij ) as follows (7) where K j in the number of cells in cluster K. The Bayesian correlation algorithm is applied to the bulk-like RNA-seq matrix (B ij ). 3-In cluster correlation: The correlation of gene i and gene j is the correlation coefficient using all cells in a specific cluster.
RESULTS
Bayesian correlation and Pearson correlation agreement increase with the number of cells
We studied the first notion of similarity: All cells correlation. To study the effect of the number of cells on the reproducibility of the results, the Bayesian correlation was computed and was compared with the Pearson correlation.
After the data processing, we ended up with four samples of 705, 1213, 2939 and 5520 cells. We refer to these samples as 1000-sample, 2000-sample, 5000-sample and 10k-sample.
Our first step was to compare our Bayesian similarity measure, using as a prior α 0 ie = 1 n and
with Pearson correlation. In doing so, we split the samples into two, randomly assigning half of the cells to group A and the other half to group B. All pairwise correlations were independently computed for each group. In Fig. 1(a) we observed that the agreement between the two samples is higher using the Bayesian method. As the number of input cells increases, the agreement between the two groups increases. In Fig. 1 are shown. This result shows that the Bayesian correlation algorithm tends to identify correlations in genes that are highly expressed, compared with the correlations identified by Pearson correlation that identifies correlations in low expressed genes. We observed some low expressed genes among the Bayesian correlations, showing that Bayesian correlation is not equivalent to a higher threshold.
Bayesian correlation is more robust than Pearson correlation to study similarity within small populations
We have shown a pronounced discrepancy between Pearson and Bayesian when the number of input cells is small. This result motivated us to study correlations within the different populations found in our data (Appendix A).
In this section, we restricted our analysis to the hepatocyte fraction. corrected data.
In Fig. 2 (a) we observed that the reproducibility for correlations within small clusters is much higher with the Bayesian correlation algorithm than with Pearson. This difference was more pronounced for a small sample size, with around 90% of irreproducible results for Pearson in the 1000-sample and 2000-sample scenarios. The Bayesian correlation was systematically lower compared with Pearson ( Fig. 2(b) ). This effect decreased with the increase in the number of input cells. The distribution of the expression of the genes in the top 3000 correlated pairs for Bayesian and Pearson correlations is shown in Fig. 2(c) . Pearson identified correlations in low expressed genes that are not considered by the Bayesian method.
Bayesian correlation is more robust than Pearson correlation to study cluster similarity
Single cell sequencing allows the study of cells individually. However, combined with clustering techniques, it is possible to obtain bulk-like RNA-seq samples from pure populations. In this section, the single cells are grouped to study Bayesian Cluster correlation.
To test the reproducibility, the UMI matrix was split into two data sets and then the transformation of Eq. 2.9 was applied. We showed that the reproducibility of our method is higher when the Bayesian method is applied.
The agreement between Pearson correlations and Bayesian correlations increased with the number of cells (Fig 3. (a) ). In Fig. 3 
Robustness of Bayesian method for a varying number of cells
Thus far, to study the reproducibility of our method, we have compared it with the Pearson correlation by splitting each of our datasets in two groups. To determine the importance of the number of cells in an experiment, we next studied the agreement between our different samples.
In the previous sections, a strong disagreement between Bayesian and Pearson was observed in the Cluster Correlations and in In Cluster Correlations. For this reason, we restricted our analysis to those two scenarios.
We first restricted our analysis the cluster identified as the hepatocyte population with the MAGIC corrected data. Fig 4(a) shows an agreement between the different samples of around 50% for the top 20000 links with the Bayesian method. On the contrary, Pearson correlation showed a low agreement between samples, which was close to 0%.
Second, we transformed our samples in bulk-like samples by means of Eq. (7) . In Fig. 4(b) we observed that the agreement between samples is around 60% with the Bayesian method when 1000 links are considered. For the Pearson correlation, the agreement between the samples is smaller and it reaches 30% when 10000 links are considered.
Bayesian in cluster correlation assign high values to cell population markers
We have shown that Bayesian correlation increases the reproducibility by assigning low correlations to low expressed genes. In this section, we demonstrate that the genes present among the most highly correlated pairs of genes are biological meaningful.
In order to investigate the biological meaning of the correlated pairs found with our Bayesian method a set of hepatocyte markers from PanglaoDB [19] was downloaded on April 17th 2019. Fig.   5 shows the percentage of genes in the top correlations that are in this public database as a function of the number links considered for the different clusters with in cluster correlation. For the 4 samples, one cluster contained more genes of the database among the top correlated links than the others. In the 4 cases, that cluster was the one identified as the hepatocyte cluster. We have shown that the Bayesian correlation can be used to identify cell populations by looking at the genes present in the top correlated pairs. To investigate further the performance of this identification method, we compared it with two analogous methods. The first method is the same method using Pearson correlation. The second method is to intersect the markers obtained with Seurat with the hepatocyte marker list.
In order to make a fair comparison, when N genes are considered with the latter identification method, we choose the number of links that results in N unique genes. Fig. 6(a) showed that for a small number of genes the Bayesian correlation algorithm selected more hepatocytes markers than Seurat or Pearson correlation. For a larger number of cells Fig. 6(b,c,d) the Bayesian correlation and Seurat showed a similar performance and both are higher than Pearson correlation. When a large number of genes (e.g. 100 genes) is considered the three methods show a similar performance.
DISCUSSION
We have presented a similarity measure of genes in scRNA-seq data, which suppresses correlations from low expressed genes, by extending the notion of Bayesian similarity from RNA-seq to scRNA-seq data. Our new Bayesian method allows scientists to study similarity between pairs of genes without discarding low expressed entities and avoiding biases. Thus, this new methodology is more resilient to noise and gives more reproducible results compared to Pearson. Moreover, the Bayesian scheme assigns high correlation to biologically relevant genes.
After splitting our samples in two groups we observed that the Bayesian correlation is more reproducible than Pearson correlation because it is not biased by low expressed genes. There was a more pronounced effect when the number of input cells was small. This result suggests that the Bayesian method can be useful to study very heterogeneous and rare populations.
We studied the correlation within different populations found in our data and focused on the hepatocyte population. Restricting the same methodology to these cells, after correcting the dropout, we observed that the reproducibility of the Bayesian correlations was higher than Pearson correlation.
As before, we have seen that this difference in the methods decreases as the number of input cells increases.
Since the All cells correlations is biased by the number of cells in a cluster, we decided to study the Cluster correlation by summing the gene expression of all cells for each gene. Clusters with low cell numbers have low total reads and therefore are less resilient to noise. Note that the Bayesian correlation accounts for the total number of reads when computing the correlation. Applying the same methodology to the clusters, we observed that Bayesian correlation are more reproducible and are not biased by low expressed genes compared to Pearson. After studying the three notions of correlation in our different samples, we have compared the results of the different samples, by comparing 1000 to 2000, 2000 to 5000 and 5000 to 10k. We studied the correlation in hepatocytes and we found that the agreement between samples was around 50% for the Bayesian method and close to 0 for the Pearson correlations. Then, we studied the cluster correlation and we showed that the samples agree more with the Bayesian correlation than with Pearson correlation.
Low expressed genes were detected in the top correlated genes using Bayesian correlations, therefore the method is not equivalent to a threshold.
To study the biological relevance of the correlated pairs identified by Bayesian correlation, we compared them with genes specific for hepatocytes from PanglaoDB. We have shown that the genes among the top correlated pairs tend to include more markers than Pearson correlation. Interestingly, when the number of cells is small, the performance of the method to identify markers is higher than the performance of Seurat [10] . There are two things that explain this fact. First, Bayesian correlation assigns higher values to high expressed genes, since markers are highly expressed they appear more.
Second, genes with a specific functionality tend to be correlated with other genes important for that function since the pathways that activate them act on the entire population. Moreover, there are different types of hepatocytes (e.g. periportal and pericentral) and in those the expression of the markers is correlated. The optimal way to modify the Bayesian correlation algorithm for cell population identification, as well as a performance comparison with other identification methods such as SingleR [5] is left for future work.
We will further extend the Bayesian notion of similarity to mass cytometry [6] and CITE-seq [67] . By combining transcriptomic and proteomic analytical tools, we will build clustering methods to merge and validate results from single cell omic datasets. Development of a pipeline that integrates transcriptomic and proteomic data will clearly allow synergistic effects that cannot be identified by studying data independently.
Although our work mainly addresses bioinformatics questions, the dataset we have generated can be very useful for experiment design for liver researchers. Firstly, we provide a dataset of healthy mouse liver sequenced with high coverage. Second, our results show which cell populations can be identified within a scRNA-seq experiment and how many input cells need to be used.
Taken together, our results show that results from Bayesian correlations are more reproducible than results from Pearson correlations and have a higher biological relevance for analysis of scRNAseq. Moreover, the number of sequenced cells have a small influence in Bayesian correlation results compared with Pearson correlation. Therefore, Bayesian correlation is a more robust measure of similarity for pairs of genes in scRNA-seq.
DATA AVAILABILITY
All data is available on genome expression omnibus reprository with the GEO accession number GSE134134.
A Cell type identification
During the preparation of this bioinformatics manuscript we created a dataset that can be useful for liver researchers. Our main goal is far from unravelling liver dynamics, however, we consider helpful for liver researchers to have an analysis of the biological samples. In this section, we describe the populations identified by Seurat clustering as well as the markers we use to classify them.
A.1 scRNA-seq samples allow the identification of multiple parenchymal and nonparenchymal cell populations
We have identified 10,10,14 and 18 different cell populations in our 1000-sample, 2000-sample, 5000sample and 10k-sample respectively. The multiple populations are showed in Fig. 7 A.2 Cell types identified and markers
1000-sample
Unsupervised clustering of the 1000 cell sample identified 10 transcriptionally distinct populations.
The different cell populations were identified using previously published markers form the literature.
• Cluster 0: Endothelial cells Markers: Pecam1,Ushbp1,Oit3,F8, Bmp2, C1qtnf1, Mmrn2, Pcdh12, Dpp4, Tek, S100a1, Tie1, Egfl7, Scarf1, Stab2, Lyve1, Icam2, Sox18, Flt4, Nr2f2 [59, 22, 26, 53, 57, 62, 28, 43, 54, 30, 18, 17, 15] .
• Cluster 1: Macrophages (Kupffer cells)
Markers: Adgre1, Csf1r, Cd163, Cd68, Marco, Vsig4, Irf7, Clec4f [35, 8, 46, 33, 38, 22] .
• Cluster 2: Stellate cells Markers: Reln, Sparc, Col1a2, Rbp1, Des, Bmp5, Lrat [27, 2, 48, 38, 49, 28, 2, 16, 47] .
• Cluster 3: Cholangiocytes Markers: Krt7 , Krt19, Epcam, Sox9, St14 [38, 32] . • Cluster 8: Hepatocytes
Markers: Alb, Ass1, Cyp2f2, Asgr1, Apoa1, Mup3, Pck1, G6pc [22, 38] .
• Cluster 9: Immune cells of Lymphoid branch
Markers: Siglech, Ly6d, Runx2 [58, 61, 77, 42] .
2000-sample
Unsupervised clustering of the 2000 cell sample identified 10 transcriptionally distinct populations.
• 
5000-sample
Unsupervised clustering of the 5000 cell sample identified 14 transcriptionally distinct populations.
The different cell populations were identified using previously published markers form the literature. [59, 22, 26, 53, 57, 62, 28, 43, 54, 30, 18, 17, 15] .
• Cluster 2: Macrophages/Kupfercells Markers: Adgre1 Csf1r, Cd163, Vsig4, Marco, Cd68, Cd5l, Irf7, Clec4f [35, 8, 46, 33, 38, 22] .
• Cluster 3 Endothelial cells:
Markers: Pecam1, Oit3, F8, Bmp2, Mmrn2, S100a1, Icam2, Egfl7, Clec4g [59, 22, 26, 53, 62, 28, 54, 30, 18, 17, 15, 79] .
• Cluster 4: T and NK cells T-cell markers: Cd3g, Cd247, Trac, CD28, Lat, Cst7, Cd3e. NK-cell markers: Nkg7, Xcl1, CCl5, Cd7, Gzmb [38, 1, 44] .
• Cluster 5 Macrophages:
Markers: Clec4f Csf1r, Cd163, Vsig4, Marco, Cd68, Cd5l [8, 46, 33, 38, 22] .
• • Cluster 9: Hepatocytes Markers: Alb, Ass1, Cyp2f2, Cyp2e1, Asgr1, Apoa1, Mup3, Pck1, G6pc [22, 38] .
• Cluster 10: Endothel cells:
Markers: Pecam1, Oit3, F8, Bmp2, Mmrn2, Dpp4, Tek , S100a1, Stab2, Sox18, Egfl7, Flt4, Nr2f2, Tie1 [59, 22, 26, 53, 57, 62, 28, 54, 18, 17, 15] .
• Cluster 11: B-cells Markers: Cd19, Ms4a1, Ltb, Cd37, Cd22, Cd79a, cd79b, Cd69 [1, 4, 38, 72] .
• Cluster 12 Immune cells of the lymphoid branch Markers: Siglech, Ly6d, Runx2, Klra17 [58, 61, 77, 42] .
• Cluster 13: Unknown
10k-sample
Unsupervised clustering of the 10k cell sample identified 17 transcriptionally distinct populations.
• Cluster 0: Endothelial cells Markers: Clec4g, Pecam1, Tek [59, 26, 79] .
• Cluster 1: Endothelial cells Markers: Clec4g, Pecam1, Dpp4, Lyve1 [22, 43, 59, 79] .
• Cluster 2: Macrophages Markers: Csf1r, Adgre1, Cd163, Vsig4, Marco, Cd68, Cd5l, Irf7, Clec4f [35, 8, 46, 46, 33, 38] .
• Cluster 3: Macrophages Markers: Adgre1, Csf1r Cd163 Vsig4 Marco Cd68 Cd5l Irf7 Clec4f [8, 33, 35, 38, 46] .
• [27, 2, 48, 38, 49, 28, 16, 9, 41, 25, 40, 47] .
• Cluster 8: Cholangiocytes
Markers: Krt7, Krt19, Sox9, Epcam, Muc1, St14 [38, 32, 45] .
• Cluster 9: Hepatocytes Markers: Alb, Apoa1, Mup3, Ass1, Cyp2f2, Cyp2e1, Asgr1, Pck1, G6pc [22, 38] .
• [27, 9, 2, 48, 38, 49, 28, 40] .
• Cluster 16: Unknown
• Cluster 17: Endothelial cells Markers: Ptprb, Pecam1 [66, 59] .
